Home
About +
Our Science +
Investors +
News +
Careers
Contact

Home
About
Our Science
Investors
News
Careers
Contact

Our Story
Meet the Team
FAQs

Inhaled IFN-β
Clinical Trials
Publications

Share Price Information
Reports & Presentations
Investor News
Shareholder Information
AIM Rule 26
Corporate Governance
Investor Calendar

Press Releases
Resources
Factsheets
TR-1/Options Press Releases

Synairgen completes Phase III recruitment

Our Science
Interferon Beta
Investigating antiviral treatment in COVID-19
Investigating antiviral treatment in COPD
Investigating antiviral treatment in asthma
Relevant Publications

About
Home
Our Story
Team
FAQs
Careers
Contact

Investors
Investors Overview
Performance
Reports & Presentations
Investor News
Analysts
Investor Calendar

News
Press Releases
Factsheets
Resources

Cookie Policy Legal Privacy Policy

© Synairgen plc. All Rights ReservedRegistered in England and Wales No. 5233429 | Site by Ether